SCHEMBL31250696

SCHEMBL31250696

COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N(CCCOCc5ccccc5)[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 4/20 0.67
▸ NTRK1 P04629 1/20 0.67
▸ RET P07949 1/20 0.67
▸ PDGFRB P09619 1/20 0.67
▸ MARK3 P27448 1/20 0.67
▸ TNK2 Q07912 1/20 0.67
▸ DDR1 Q08345 1/20 0.67
▸ MAP4K2 Q12851 1/20 0.67
▸ MAP3K11 Q16584 1/20 0.67
▸ DDR2 Q16832 1/20 0.67
▸ MARK2 Q7KZI7 1/20 0.67
▸ MAP4K3 Q8IVH8 1/20 0.67
▸ MAP4K1 Q92918 1/20 0.67
▸ AURKB Q96GD4 1/20 0.67
▸ EIF2AK1 Q9BQI3 1/20 0.67
▸ MAP3K20 Q9NYL2 1/20 0.67
▸ STK26 Q9P289 1/20 0.67
▸ TNIK Q9UKE5 1/20 0.67
▸ MAP4K5 Q9Y4K4 1/20 0.67
▸ FGFR2 P21802 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31250747 0.88 FGFR1 (0.75) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL31250962 0.87 FGFR1 (0.69) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL31250907 0.85 FGFR1 (0.71) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL62562 0.85 FGFR1 (0.82) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL31251043 0.82 FGFR1 (0.66) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL13574162 0.82 FGFR1 (0.77) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL13574146 0.82 FGFR1 (0.77) FGFR1NTRK1RETPDGFRBMARK3
SCHEMBL63830 0.82 FGFR1 (0.77) FGFR1NTRK1RETPDGFRBMARK3
Fexagratinib SCHEMBL15250892 0.81 FGFR1 (1.00) FGFR1NTRK1RETPDGFRBMARK3
Azd-4547 SCHEMBL22132858 0.81 FGFR1 (1.00) FGFR1NTRK1RETPDGFRBMARK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720058-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF Casma Therapeutics, Inc. (US) 2026-04-08 — — EP disclosed
WO-2024249291-A2 BIFUNCTIONAL DEGRADERS AND USES THEREOF CASMA THERAPEUTICS, INC. (US) 2024-12-05 — — WO disclosed
Send feedback